Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Kathryn J. Ruddy, Maria A. Caligo, Laura Spugnesi et al.|Breast Cancer Research|2016Cited by 118
Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic reviewSimone Karlsson Terp, Inge Søkilde Pedersen, Malene Pontoppidan Stoico et al.|Clinical Epigenetics|2023Cited by 67
Genetic Testing and Clinical Management Practices for Variants in Non-<i>BRCA1</i>/<i>2</i> Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M. Nielsen, Jana Soukupová, Iris L. Romero et al.|JCO Precision Oncology|2018Cited by 28
Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, DenmarkJulie Støve Bødker, Martin Bøgsted, Mads Sønderkær et al.|Cancers|2020Cited by 20
DNA methylation biomarkers in peripheral blood of patients with head and neck squamous cell carcinomas. A systematic reviewChristian Sander Danstrup, Michael Gaihede, Mette Marcussen et al.|PLoS ONE|2020Cited by 11